Bifidobacterium activates the function of DCs within tumors, increasing the infiltration of CD8+ T cells and thereby enhancing the efficacy of anti-PD-L1 therapy to control tumor progression (Sivan et al., 2015). Here, CD8A is linked to neoplasm.